biotech / news / / Scientific Computing World
The investment, revealed by Prime Minister Keir Starmer, will be directed toward two of the company’s key sites in Cambridge and Macclesfield.
AstraZeneca is investing £300 million into its UK operations.
KEY POINTS
- The investment targets AstraZeneca's key sites in Cambridge and Macclesfield.
- This move reverses AstraZeneca's previous decision to cut back UK spending.
- AstraZeneca's renewed investment signals increased confidence in the UK's life sciences sector.
COMPANIES
Summarized by Newsio from Scientific Computing World. How we summarize →